Mucus Relief Dm Cough Tablet, Film Coated
NDC Package 50844-633-11

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Mucus Relief Dm Cough (dextromethorphan hbr and guaifenesin) tablets is take with a full glass of wateradults and children 12 years and over: 1 tablet every 4 hours. This formulation utilizes a tablet, film coated delivery system. Marketed by L.n.k. International, Inc., this product is identified by NDC 50844-633 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
50844-633-11
Package Description
1 BOTTLE, PLASTIC in 1 CARTON / 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Product Code
50844-633
11-Digit Billing Format
50844063311
RxNorm Crosswalk
  • RxCUI: 1147685 - dextromethorphan HBr 20 MG / guaiFENesin 400 MG Oral Tablet
  • RxCUI: 1147685 - dextromethorphan hydrobromide 20 MG / guaifenesin 400 MG Oral Tablet
  • RxCUI: 1147685 - guaifenesin 400 MG / dextromethorphan HBr 20 MG Oral Tablet

Clinical Specifications

Proprietary Name
Mucus Relief Dm Cough
Non-Proprietary Name
Dextromethorphan Hbr And Guaifenesin
Substance Name
Dextromethorphan Hydrobromide; Guaifenesin
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Take with a full glass of wateradults and children 12 years and over: 1 tablet every 4 hours. Do not take more than 6 tablets in 24 hours.children under 12 years: do not use

Regulatory & Marketing

Labeler Name
L.n.k. International, Inc.
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
08-07-2023
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50844-633-11 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 60 tablet, film coated in 1 bottle, plastic of Mucus Relief Dm Cough, a human over the counter drug labeled by L.n.k. International, Inc.. This tablet, film coated is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by L.n.k. International, Inc. on August 07, 2023. The current certification is valid through December 31, 2027.

How is this L.n.k. International, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50844063311. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
50844-633-11
11-Digit CMS (5-4-2)
50844-0633-11

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.